Dr. Goulart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-667-2778Fax+1 206-288-1435
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2007 - 2011
- University of WashingtonResidency, Internal Medicine, 2005 - 2007
- Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1997
Certifications & Licensure
- WA State Medical License 2007 - 2025
Publications & Presentations
PubMed
- 6 citationsImpact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.Perrin E Romine, Qin Sun, Catherine Fedorenko, Li Li, Mariel Tang
JCO Oncology Practice. 2022-06-01 - 108 citationsA Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.Cristina P. Rodriguez, Qian Vicky Wu, Jenna M. Voutsinas, Jonathan R. Fromm, Xiuyun Jiang
Clinical Cancer Research. 2020-02-15 - 93 citationsLung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.Bernardo H. L. Goulart, Mark Bensink, David G. Mummy, Scott D. Ramsey
Journal of the National Comprehensive Cancer Network. 2012-02-01
Press Mentions
- What's a Cancer Registry?March 22nd, 2021
- MD Anderson Leads List of Top-Tier Cancer HospitalsJuly 29th, 2020
- Durvalumab Phase III Trial Could Change Mesothelioma CareMay 28th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: